Premium
Adjunctive brexpiprazole effective after inadequate antidepressant response
Publication year - 2015
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30093
Subject(s) - adjunctive treatment , antidepressant , medicine , antipsychotic , depression (economics) , placebo , schizophrenia (object oriented programming) , pharmacology , psychiatry , anxiety , economics , macroeconomics , alternative medicine , pathology
The novel antipsychotic brexpiprazole improved depression symptoms compared with placebo when used as adjunctive therapy for patients who did not respond adequately to a course of antidepressant treatment, according to two studies that examined a total of three different daily doses of brexpiprazole.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom